AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
BRIGHTON, Colo., March 19, 2017 -- Brighton Eye Associates is pleased to announce to the community the introduction of the High Definition CIRRUS HD-OCT technology as part of an enhanced eye examination. The Ocular Coherence Tomography or OCT provides a microscopic 3-D evaluation of the eye. Especially important is its use for macular degeneration and for glaucoma. It is also valuable for other eye conditions including diabetes and high blood pressure. Doctors are able to see the difference between wet macular degeneration and dry macular degeneration.
Glaucoma is usually seen in people over the age of 40. People do not know they have glaucoma because it has no symptoms. Early detection, monitoring, and treatment slows the progress of glaucoma. The new High Definition CIRRUS HD-OCT instrument allows for a 3D examination of the eye and much earlier diagnosis of glaucoma.
“We are excited to offer the new HD OCT instrument to our patients,” said Dr. Rodney D. Fair, OD. “Dr. Baker, Dr. Sanchez and I are always looking for better ways to serve the vision needs of our patients and this instrument is the latest addition to our state-of-the-art technology used to help our patients at Brighton Eye Associates.”
Visit http://brightoneye.net/ for more details.
Brighton Eye Associates 1001 E. Bridge Street Brighton, CO 80601 (303) 659-3036
